Hammers Recommends Revisiting Vaccines in Renal Cell Carcinoma
Hans J. Hammers, MD, PhD, discusses findings from a phase I study of alpha-1, 3 galactosyltransferase-expressing allogeneic RCC immunotherapy.
Radiation Therapy, Chemotherapy, Targeted Therapy, and Possibly Immunotherapy in Localized Sarcoma
Researchers offer a review of the role of adjuvant or neoadjuvant chemotherapy, targeted therapy, and immunotherapy in localized soft tissue sarcoma.
A Phase II Trial of Cetuximab and Docetaxel With Radiation for Head and Neck Cancer
The use of low-dose radiotherapy may offer transient benefits; nonetheless the potential for palliative care exists.
Locoregional Therapeutics: Using One's Own Tumor as a Vaccine
A locoregional approach to cancer vaccines, when combined with immunmodulatory antibody therapy, could generate a significant anti-tumor response.
